Market Cap 2.01B
Revenue (ttm) 3.79B
Net Income (ttm) -910.00M
EPS (ttm) N/A
PE Ratio 6.66
Forward PE 6.57
Profit Margin -23.99%
Debt to Equity Ratio 1.36
Volume 1,510,492
Avg Vol 3,634,838
Day's Range N/A - N/A
Shares Out 199.48M
Stochastic %K 3%
Beta 1.00
Analysts Sell
Price Target $12.88

Company Profile

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 844 848 0137
Address:
13320 Ballantyne Corporate Place, Charlotte, United States
JohnTill
JohnTill Nov. 21 at 3:22 PM
$XRAY Since TA is more of an art than a science I had my eye on the 9.67 level (1998 non-dividend adjusted high) and ~9.90, which should act as major support from the dividend adjusted 1999 lows. Either way - high 9s should be an important levels. Managed to score a bunch 9.87-9.92 the past two days getting me to almost a $10 avg. but lower bids still waiting. Did we bottom yesterday? We shall see.
0 · Reply
Iightning
Iightning Nov. 21 at 2:40 AM
1ightning® Options Trade Alert (Actionable) | Buy $XRAY Dec 19 $12 Call | Enter: $0.11 Exit: $0.15 | Profit: 37.09% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 20 at 12:05 AM
1ightning® Options Trade Alert (Actionable) | Buy $XRAY Dec 19 $12 Call | Enter: $0.11 Exit: $0.15 | Profit: 37.09% ROI | https://1ightning.com
0 · Reply
JohnTill
JohnTill Nov. 19 at 3:40 PM
$XRAY 6.3% well covered dividend. Highly profitable and turn around plan in play. Looking at the chart I am puzzled on how this is not on more people's radar. 1998 support levels!
1 · Reply
Iightning
Iightning Nov. 19 at 8:20 AM
1ightning® Options Trade Alert (Actionable) | Buy $XRAY Dec 19 $12 Call | Enter: $0.11 Exit: $0.15 | Profit: 37.09% ROI | https://1ightning.com
0 · Reply
TheInvestingMusician
TheInvestingMusician Nov. 18 at 8:51 PM
$XRAY been watching this one for months, finally took a starter position. Might be more tax loss selling to come, but in less this company is on SERIOUS trouble…we may be near bottom. Let’s just hope the dividend is safe!
0 · Reply
JohnTill
JohnTill Nov. 18 at 3:21 PM
$XRAY Started a solid position over the past two days at 10.34 dollars, with bids in high 9s if the stock shows additional weakness. It is easy to focus on past mistakes and revenue contraction, but my attention is on what comes next. The new CEO has a very strong track record and appears to have a credible turnaround plan. The stock is down about 85 percent over the last three years and is trading near 1998 levels. The price to earnings ratio is 6 and 1/3 of comparable companies. It remains highly profitable across a broad product lineup and great cash flows. The dividend is 6.2 percent and is very well covered by current earnings. I am willing to catch falling knives given this information and market. There is also a massive falling wedge on the chart and it would only take a touch of good news to see a gap fill at $20-22 in 2026.
1 · Reply
MrNotSoNice
MrNotSoNice Nov. 15 at 4:09 PM
$XRAY Don’t people fix their teeth anymore? 😬
0 · Reply
11thestate
11thestate Nov. 14 at 4:34 PM
If you missed the deadline, don’t miss this update. This is probably the most useful info you’ve read in years about $XRAY — how you can actually recover something: https://11th.com/cases/dentsplysirona-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=11142025
0 · Reply
CeaseNDesist
CeaseNDesist Nov. 12 at 2:33 PM
$XRAY horrible, I'm out
0 · Reply
Latest News on XRAY
DENTSPLY SIRONA Inc. (XRAY) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 11:06 AM EST - 15 days ago

DENTSPLY SIRONA Inc. (XRAY) Q3 2025 Earnings Call Transcript


Dentsply Sirona Reports Third Quarter 2025 Results

Nov 6, 2025, 8:00 AM EST - 15 days ago

Dentsply Sirona Reports Third Quarter 2025 Results


Dentsply Sirona to Participate in Upcoming Investor Conferences

Aug 26, 2025, 4:30 PM EDT - 3 months ago

Dentsply Sirona to Participate in Upcoming Investor Conferences


Dentsply Sirona: Turnaround Potential And Digital Workflows

Aug 19, 2025, 9:11 AM EDT - 3 months ago

Dentsply Sirona: Turnaround Potential And Digital Workflows


DENTSPLY SIRONA Inc. (XRAY) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 9:15 AM EDT - 3 months ago

DENTSPLY SIRONA Inc. (XRAY) Q2 2025 Earnings Call Transcript


Dentsply Sirona Reports Second Quarter 2025 Results

Aug 7, 2025, 6:00 AM EDT - 3 months ago

Dentsply Sirona Reports Second Quarter 2025 Results


Buying Dentsply Sirona

Jun 4, 2025, 6:34 PM EDT - 6 months ago

Buying Dentsply Sirona


Dentsply Sirona Declares Quarterly Cash Dividend

May 27, 2025, 4:15 PM EDT - 6 months ago

Dentsply Sirona Declares Quarterly Cash Dividend


DENTSPLY SIRONA Inc. (XRAY) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:04 AM EDT - 7 months ago

DENTSPLY SIRONA Inc. (XRAY) Q1 2025 Earnings Call Transcript


Dentsply Sirona Reports First Quarter 2025 Results

May 8, 2025, 6:00 AM EDT - 7 months ago

Dentsply Sirona Reports First Quarter 2025 Results


JohnTill
JohnTill Nov. 21 at 3:22 PM
$XRAY Since TA is more of an art than a science I had my eye on the 9.67 level (1998 non-dividend adjusted high) and ~9.90, which should act as major support from the dividend adjusted 1999 lows. Either way - high 9s should be an important levels. Managed to score a bunch 9.87-9.92 the past two days getting me to almost a $10 avg. but lower bids still waiting. Did we bottom yesterday? We shall see.
0 · Reply
Iightning
Iightning Nov. 21 at 2:40 AM
1ightning® Options Trade Alert (Actionable) | Buy $XRAY Dec 19 $12 Call | Enter: $0.11 Exit: $0.15 | Profit: 37.09% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 20 at 12:05 AM
1ightning® Options Trade Alert (Actionable) | Buy $XRAY Dec 19 $12 Call | Enter: $0.11 Exit: $0.15 | Profit: 37.09% ROI | https://1ightning.com
0 · Reply
JohnTill
JohnTill Nov. 19 at 3:40 PM
$XRAY 6.3% well covered dividend. Highly profitable and turn around plan in play. Looking at the chart I am puzzled on how this is not on more people's radar. 1998 support levels!
1 · Reply
Iightning
Iightning Nov. 19 at 8:20 AM
1ightning® Options Trade Alert (Actionable) | Buy $XRAY Dec 19 $12 Call | Enter: $0.11 Exit: $0.15 | Profit: 37.09% ROI | https://1ightning.com
0 · Reply
TheInvestingMusician
TheInvestingMusician Nov. 18 at 8:51 PM
$XRAY been watching this one for months, finally took a starter position. Might be more tax loss selling to come, but in less this company is on SERIOUS trouble…we may be near bottom. Let’s just hope the dividend is safe!
0 · Reply
JohnTill
JohnTill Nov. 18 at 3:21 PM
$XRAY Started a solid position over the past two days at 10.34 dollars, with bids in high 9s if the stock shows additional weakness. It is easy to focus on past mistakes and revenue contraction, but my attention is on what comes next. The new CEO has a very strong track record and appears to have a credible turnaround plan. The stock is down about 85 percent over the last three years and is trading near 1998 levels. The price to earnings ratio is 6 and 1/3 of comparable companies. It remains highly profitable across a broad product lineup and great cash flows. The dividend is 6.2 percent and is very well covered by current earnings. I am willing to catch falling knives given this information and market. There is also a massive falling wedge on the chart and it would only take a touch of good news to see a gap fill at $20-22 in 2026.
1 · Reply
MrNotSoNice
MrNotSoNice Nov. 15 at 4:09 PM
$XRAY Don’t people fix their teeth anymore? 😬
0 · Reply
11thestate
11thestate Nov. 14 at 4:34 PM
If you missed the deadline, don’t miss this update. This is probably the most useful info you’ve read in years about $XRAY — how you can actually recover something: https://11th.com/cases/dentsplysirona-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=11142025
0 · Reply
CeaseNDesist
CeaseNDesist Nov. 12 at 2:33 PM
$XRAY horrible, I'm out
0 · Reply
JarvisFlow
JarvisFlow Nov. 10 at 1:27 PM
Barrington Research has updated their rating for Dentsply Sirona ( $XRAY ) to Outperform with a price target of 14.
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 8:17 PM
JP Morgan updates rating for Dentsply Sirona ( $XRAY ) to Neutral, target set at 14 → 12.
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 6:51 PM
Wells Fargo has updated their rating for Dentsply Sirona ( $XRAY ) to Equal-Weight with a price target of 12.
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 12:38 PM
William Blair has adjusted their stance on Dentsply Sirona ( $XRAY ), setting the rating to Market Perform.
0 · Reply
RunnerSignals
RunnerSignals Nov. 7 at 4:26 AM
Wild Thursday: The Good, Bad & Ugly $DDOG $DASH $DUOL $XRAY $COP One killer earnings report, three brutal selloffs. Full breakdown inside https://stocksrunner.com/news/2025-11-06-late-night-market-recap-shows-mixed-results-thursday
0 · Reply
d_risk
d_risk Nov. 6 at 4:20 PM
$XRAY - DENTSPLY SIRONA Inc. Common Stock - 10Q - Updated Risk Factors XRAY flags heightened impairment risk after a $253M goodwill charge in Q3 2025 for Implant Prosthetic Solutions, citing tariffs, lower volumes, and ongoing vulnerability to market shifts. #HealthcareEquipment #VolumeDecline #MarketVolatility #TariffImpact #GoodwillImpairment 🟢 Added 🟠 Removed https://d-risk.ai/XRAY/10-Q/2025-11-06
0 · Reply
ZacksResearch
ZacksResearch Nov. 6 at 3:44 PM
$XRAY takes a hit with weak Q3 results—where's the recovery? 📉 EPS dropped 26.5% YoY, missing the Zacks Consensus Estimate by 17.8%. Revenue fell 4.9% YoY with the weak results dragging the stock down nearly 8.8% pre-market. Understand the full impact here 👉 https://www.zacks.com/stock/news/2786991/xray-stock-declines-on-q3-earnings-miss-lower-2025-eps-view?cid=sm-stocktwits-2-2786991-body-19805&ADID=SYND_STOCKTWITS_TWEET_2_2786991_BODY_19805
0 · Reply
ZacksResearch
ZacksResearch Nov. 6 at 2:44 PM
$XRAY slides after earnings miss and guidance cut. 🦷 Q3 results came in below estimates, and the 2025 EPS view was lowered as segment weakness continues to drag on performance. Full story here 👉 https://www.zacks.com/stock/news/2786991/xray-stock-declines-on-q3-earnings-miss-lower-2025-eps-view?cid=sm-stocktwits-2-2786991-teaser-19803&ADID=SYND_STOCKTWITS_TWEET_2_2786991_TEASER_19803
0 · Reply
OpenOutcrier
OpenOutcrier Nov. 6 at 1:55 PM
$XRAY (-11.6% pre) Dentsply Sirona (NASDAQ:XRAY) Posts Better-Than-Expected Sales In Q3 But Stock Drops https://ooc.bz/l/83514
0 · Reply
Parker8597
Parker8597 Nov. 6 at 1:42 PM
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 1 at 3:57 AM
$XRAY Share Price: $12.60 Contract Selected: Apr 17, 2026 $10 Calls Buy Zone: $2.63 – $3.26 Target Zone: $4.70 – $5.74 Potential Upside: 68% ROI Time to Expiration: 167 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Trader_Ty
Trader_Ty Oct. 31 at 3:27 PM
$XRAY Breakeven cut with ER next week. Back to WL
0 · Reply